Scientists should focus on the interactions between T and B cells to find better treatments for autoimmune disorders, such as ...

Germline-targeting epitope scaffold nanoparticles elicit rare broadly neutralizing antibody (bnAb) precursors against human ...

Some niacin seems to be needed for the synthesis of GTF and is essential for controlling blood sugar because it could stop ...

CAR T-cell therapy, which has been a breakthrough in certain blood cancers, is now showing promise in treating and even ...

Dormant Epstein-Barr virus (EBV) becomes activated and triggers inflammation during MS disease activity, a study suggests.

The Wistar Institute's Paul M. Lieberman, Ph.D., and lab team led by senior staff scientist and first author, Samantha Soldan, Ph.D., have demonstrated how B cells infected with the Epstein-Barr virus ...

The Wistar Institute's Paul M. Lieberman, Ph.D., and lab team led by senior staff scientist and first author Samantha Soldan, Ph.D., have demonstrated how B cells infected with the Epstein-Barr virus ...

Inebilizumab -cdon, a monoclonal antibody that depletes B cells, reduces the risk for flares without showing any new safety ...

Recent research suggests that short bouts of moderate to intense exercise could boost the efficacy of a monoclonal antibody ...

Using a combination of cutting-edge immunologic technologies, researchers have successfully stimulated animals' immune systems to induce rare precursor B cells of a class of HIV broadly neutralizing ...